Effects of growth hormone replacement therapy on bone mineral density in growth hormone deficient adults: A meta-analysis

International Journal of Endocrinology

Volumn 2013, Issue , 2013, Pages

  Xue, Peng ^a   Wang, Yan ^a   Yang, Jie ^a   Li, Yukun ^a  

^a HEBEI MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

GROWTH HORMONE; SOMATOMEDIN C;

ADULT; ARTICLE; BONE DENSITY; DIAGNOSTIC IMAGING EQUIPMENT; DUAL ENERGY X RAY ABSORPTIOMETRY; DUAL ENERGY X RAY ABSORPTIOMETRY SCANNER; EUROPE; FEMUR NECK; GEOGRAPHY; GROWTH HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; META ANALYSIS; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PUBLISHING; SENSITIVITY ANALYSIS; SPINE; SYSTEMATIC REVIEW; TREATMENT DURATION; WESTERN HEMISPHERE;

EID: 84877279398     PISSN: 16878337     EISSN: 16878345     Source Type: Journal    
DOI: 10.1155/2013/216107     Document Type: Article

References (56)

1. Shimon I., Growth hormone replacement for adult growth hormone deficiency. Expert Opinion on Pharmacotherapy 2003 4 11 1977 1983 2-s2.0-0242659157 10.1517/14656566.4.11.1977 (Pubitemid 37408109)
2. Ernst M., Froesch E. R., Growth hormone dependent stimulation of osteoblast-like cells in serum-free cultures via local synthesis of insulin-like growth factor I. Biochemical and Biophysical Research Communications 1988 151 1 142 147 2-s2.0-0023857232 (Pubitemid 18074155)
3. Joung Y. H., Lim E. J., Darvin P., Chung S. C., Jang J. W., Do Park K., Lee H. K., Kim H. S., Park T., Yang Y. M., MSM enhances GH signaling via the Jak2/STAT5b pathway in osteoblast-like cells and osteoblast differentiation through the activation of STAT5b in MSCs. PLoS One 2012 7 10 e47477
4. Carroll P. V., Christ E. R., Bengtsson B. Å., Carlsson L., Christiansen J. S., Clemmons D., Hintz R., Ho K., Laron Z., Sizonenko P., Sönksen P. H., Tanaka T., Thorner M., Growth hormone deficiency in adulthood and the effects of growth hormone replacement: a review. Journal of Clinical Endocrinology and Metabolism 1998 83 2 382 395 2-s2.0-2142673373 10.1210/jc.83.2.382 (Pubitemid 28496511)
5. Geisler A., Lass N., Reinsch N., Uysal Y., Singer V., Ravens-Sieberer U., Reinehr T., Quality of life in children and adolescents with growth hormone deficiency: association with growth hormone treatment. Hormone Research in Paediatrics 2012 78 2 94 99 10.1159/000341151
6. Kann P., Piepkorn B., Schehler B., Andreas J., Lotz J., Prellwitz W., Beyer J., Effect of long-term treatment with GH on bone metabolism, bone mineral density and bone elasticity in GH-deficient adults. Clinical Endocrinology 1998 48 5 561 568 2-s2.0-0031747438 10.1046/j.1365-2265.1998.00439.x (Pubitemid 28252992)
7. Tritos N. A., Hamrahian A. H., King D., Greenspan S. L., Cook D. M., Jonsson P. J., Wajnrajch M. P., Koltowska-Haggstrom M., Biller B. M., A longer interval without GH replacement and female gender are associated with lower bone mineral density in adults with childhood-onset GH deficiency: a KIMS database analysis. European Journal of Endocrinology 2012 167 3 343 351 10.1530/EJE-12-0070
8. Wüster C., Abs R., Bengtsson B. A., Bennmarker H., Feldt-Rasmussen U., Hernberg-Ståhl E., Monson J. P., Westberg B., Wilton P., The influence of growth hormone deficiency, growth hormone replacement therapy, and other aspects of hypopituitarism on fracture rate and bone mineral density. Journal of Bone and Mineral Research 2001 16 2 398 405 2-s2.0-0035134092 (Pubitemid 32106717)
9. Rosén T., Wilhelmsen L., Landin-Wilhelmsen K., Lappas G., Bengtsson B. Å., Increased fracture frequency in adult patients with hypopituitarism and GH deficiency. European Journal of Endocrinology 1997 137 3 240 245 2-s2.0-0030882291 10.1530/eje.0.1370240 (Pubitemid 27405107)
10. Fideleff H. L., Boquete H. R., Stalldecker G., Giaccio A. V., Sobrado P. G. V., Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients. Growth Hormone and IGF Research 2008 18 4 318 324 2-s2.0-44349107604 10.1016/j.ghir.2008.01.002 (Pubitemid 351729191)
11. van den Heijkant S., Hoorweg-Nijman G., Huisman J., Drent M., van der Pal H., Kaspers G. J., Delemarre-van de Waal H., Effects of growth hormone therapy on bone mass, metabolic balance, and well-being in young adult survivors of childhood acute lymphoblastic leukemia. Journal of Pediatric Hematology/Oncology 2011 33 6 e231 e238 10.1097/MPH.0b013e31821bbe7a
12. Suganuma N., Furuhashi M., Hirooka T., Moriwaki T., Hasegawa Y., Mori O., Ogawa M., Bone mineral density in adult patients with Turner's syndrome: analyses of the effectiveness of GH and ovarian steroid hormone replacement therapies. Endocrine Journal 2003 50 3 263 269 2-s2.0-0037932676 10.1507/endocrj.50.263 (Pubitemid 36830002)
13. Hansen T. B., Brixen K., Vahl N., Jørgensen J. O. L., Christiansen J. S., Mosekilde L., Hagen C., Effects of 12 months of growth hormone (GH) treatment on calciotropic hormones, calcium homeostasis, and bone metabolism in adults with acquired GH deficiency: a double blind, randomized, placebo-controlled study. Journal of Clinical Endocrinology and Metabolism 1996 81 9 3352 3359 2-s2.0-0029821102 10.1210/jc.81.9.3352 (Pubitemid 26296215)
14. Johannsson G., Rosén T., Bosaeus I., Sjöström L., Bengtsson B. Å., Two years of growth hormone (GH) treatment increases bone mineral content and density in hypopituitary patients with adult-onset GH deficiency. Journal of Clinical Endocrinology and Metabolism 1996 81 8 2865 2873 2-s2.0-0029812889 10.1210/jc.81.8.2865 (Pubitemid 26323877)
15. Rodríguez-Arnao J., James I., Jabbar A., Trainer P. J., Perrett D., Besser G. M., Ross R. J. M., Serum collagen crosslinks as markers of bone turn-over during GH replacement therapy in growth hormone deficient adults. Clinical Endocrinology 1998 48 4 455 462 2-s2.0-0031808446 10.1046/j.1365-2265. 1998.00405.x (Pubitemid 28258818)
16. Cuneo R. C., Judd S., Wallace J. D., Perry-Keene D., Burger H., Lim-Tio S., Strauss B., Stockigt J., Topliss D., Alford F., Hew L., Bode H., Conway A., Handelsman D., Dunn S., Boyages S., Cheung N. W., Hurley D., The Australian multicenter trial of growth hormone (GH) treatment in GH- deficient adults. Journal of Clinical Endocrinology and Metabolism 1998 83 1 107 116 2-s2.0-14444282422 10.1210/jc.83.1.107 (Pubitemid 28498319)
17. Biller B. M. K., Sesmilo G., Baum H. B. A., Hayden D., Schoenfeld D., Klibanski A., Withdrawal of long-term physiological growth hormone (GH) administration: differential effects on bone density and body composition in men with adult-onset GH deficiency. Journal of Clinical Endocrinology and Metabolism 2000 85 3 970 976 2-s2.0-0034453773 10.1210/jc.85.3.970 (Pubitemid 32269335)
18. Koranyi J., Svensson J., Götherström G., Sunnerhagen K. S., Bengtsson B. Å., Johannsson G., Baseline characteristics and the effects of five years of GH replacement therapy in adults with GH deficiency of childhood or adulthood onset: a comparative, prospective study. Journal of Clinical Endocrinology and Metabolism 2001 86 10 4693 4699 2-s2.0-0034751043 10.1210/jc.86.10.4693 (Pubitemid 33026071)
19. Lanzi R., Losa M., Villa I., Gatti E., Sirtori M., Dal Fiume C., Rubinacci A., GH replacement therapy increases plasma osteoprotegerin levels in GH-deficient adults. European Journal of Endocrinology 2003 148 2 185 191 2-s2.0-0037292935 10.1530/eje.0.1480185 (Pubitemid 36312939)
20. Underwood L. E., Attie K. M., Baptista J., Growth hormone (GH) dose-response in young adults with childhood-onset GH deficiency: a two-year, multicenter, multiple-dose, Placebo-controlled study. Journal of Clinical Endocrinology and Metabolism 2003 88 11 5273 5280 2-s2.0-0344011427 10.1210/jc.2003-030204 (Pubitemid 37452727)
21. Hubina E., Kovacs L., Szabolcs I., Szucs N., Toth M., Racz K., Czirjak S., Gorombey Z., Goth M. I., The effect of gender and age on growth hormone replacement in growth hormone-deficient patients. Hormone and Metabolic Research 2004 36 4 247 253 10.1055/s-2004-814458 (Pubitemid 38626414)
22. Bravenboer N., Holzmann P. J., Ter Maaten J. C., Stuurman L. M., Roos J. C., Lips P., Effect of long-term growth hormone treatment on bone mass and bone metabolism in growth hormone-deficient men. Journal of Bone and Mineral Research 2005 20 10 1778 1784 2-s2.0-25444453727 10.1359/JBMR.050613 (Pubitemid 41361878)
23. Arwert L. I., Roos J. C., Lips P., Twisk J. W. R., Manoliu R. A., Drent M. L., Effects of 10 years of growth hormone (GH) replacement therapy in adult GH-deficient men. Clinical Endocrinology 2005 63 3 310 316 2-s2.0-24144432081 10.1111/j.1365-2265.2005.02343.x (Pubitemid 41233449)
24. Boguszewski C. L., Meister L. H. F., Zaninelli D. C. T., Radominski R. B., One year of GH replacement therapy with a fixed low-dose regimen improves body composition, bone mineral density and lipid profile of GH-deficient adults. European Journal of Endocrinology 2005 152 1 67 75 2-s2.0-13244275093 10.1530/eje.1.01817 (Pubitemid 40192469)
25. Benedini S., Dalle Carbonare L., Albiger N., Scanarini M., Bilora F., Petrobelli F., Giannini S., Mantero F., Scaroni C., Effect of short-term therapy with recombinant human growth hormone (GH) on metabolic parameters and preclinical atherosclerotic markers in hypopituitary patients with growth hormone deficiency. Hormone and Metabolic Research 2006 38 1 16 21 2-s2.0-33645744658 10.1055/s-2006-924970
26. Snyder P. J., Biller B. M. K., Zagar A., Jackson I., Arafah B. M., Nippoldt T. B., Cook D. M., Mooradian A. D., Kwan A., Scism-Bacon J., Chipman J. J., Hartman M. L., Effect of growth hormone replacement on BMD in adult-onset growth hormone deficiency. Journal of Bone and Mineral Research 2007 22 5 762 770 2-s2.0-34447500560 10.1359/jbmr.070205 (Pubitemid 351339106)
27. Gotherstrom G., Bengtsson B. A., Bossæus I., Johansson G., Svensson J., Ten-year GH replacement increase bone mineral density in hypopituitary patients with adult onset GH deficiency. European Journal of Endocrinology 2007 156 1 55 64 2-s2.0-34147153476 10.1530/eje.1.02317 (Pubitemid 46561839)
28. Rota F., Savanelli M. C., Tauchmanova L., Savastano S., Lombardi G., Colao A., Di Somma C., Bone density and turnover in young adult patients with growth hormone deficiency after 2-year growth hormone replacement according with gender. Journal of Endocrinological Investigation 2008 31 2 94 103 2-s2.0-42649103615 (Pubitemid 351596968)
29. Conway G. S., Szarras-Czapnik M., Racz K., Keller A., Chanson P., Tauber M., Zacharin M., Treatment for 24 months with recombinant human GH has a beneficial effect on bone mineral density in young adults with childhood-onset GH deficiency. European Journal of Endocrinology 2009 160 6 899 907 2-s2.0-66149085630 10.1530/EJE-08-0436
30. Elbornsson M., Gotherstrom G., Bosaeus I., Bengtsson B. A., Johannsson G., Svensson J., Fifteen years of GH replacement increases bone mineral density in hypopituitary patients with adult-onset GH deficiency. European Journal of Endocrinology 2012 166 5 787 795 10.1530/EJE-11-1072
31. Leung D. W., Spencer S. A., Cachianes G., Hammonds R. G., Collins C., Henzel W. J., Barnard R., Waters M. J., Wood W. I., Growth hormone receptor and serum binding protein: purification, cloning and expression. Nature 1987 330 6148 537 543 2-s2.0-0023635603 (Pubitemid 17164350)
32. Andreassen M., Frystyk J., Faber J., Kristensen L. O., GH activity and markers of inflammation: a crossover study in healthy volunteers treated with GH and a GH receptor antagonist. European Journal of Endocrinology 2012 166 5 811 819 10.1530/EJE-11-1009
33. Mathews L. S., Hammer R. E., Brinster R. L., Palmiter R. D., Expression of insulin-like growth factor I in transgenic mice with elevated levels of growth hormone is correlated with growth. Endocrinology 1988 123 1 433 437 2-s2.0-0023688545
34. Becker N. S., Verdu P., Georges M., Duquesnoy P., Froment A., Amselem S., Le Bouc Y., Heyer E., The role of GHR and IGF1 genes in the genetic determination of African pygmies' short stature. European Journal of Human Genetics 2012 10.1038/ejhg.2012.223
35. Barner C., Petersson M., Eden Engstrom B., Hoybye,: C., Effects on insulin sensitivity and body composition of combination therapy with GH and IGF1 in GH deficient adults with type 2 diabetes. European Journal of Endocrinology 2012 167 5 697 703 10.1530/EJE-12-0484
36. Holly J. M. P., Wass J. A. H., Insulin-like growth factors; autocrine, paracrine or endocrine? New perspectives of the somatomedin hypothesis in the light of recent developments. Journal of Endocrinology 1989 122 3 611 618 2-s2.0-0024437318 (Pubitemid 19220615)
37. Arnaldez F. I., Helman L. J., Targeting the insulin growth factor receptor 1. Hematology/Oncology Clinics of North America 2012 26 3 527 542 10.1016/j.hoc.2012.01.004
38. Yakar S., Rosen C. J., Beamer W. G., Ackert-Bicknell C. L., Wu Y., Liu J. L., Ooi G. T., Setser J., Frystyk J., Boisclair Y. R., LeRoith D., Circulating levels of IGF-1 directly regulate bone growth and density. Journal of Clinical Investigation 2002 110 6 771 781 2-s2.0-0036740049 10.1172/JCI200215463
39. Kassem M., Mosekilde L., Eriksen E. F., Growth hormone stimulates proliferation of normal human bone marrow stromal osteoblast precursor cells in vitro. Growth Regulation 1994 4 3 131 135 2-s2.0-0027996086 (Pubitemid 24315352)
40. Wit J. M., Camacho-Hubner C., Endocrine regulation of longitudinal bone growth. Endocrine Development 2011 21 30 41 10.1159/000328119
41. Baroncelli G. I., Bertelloni S., Ceccarelli C., Cupelli D., Saggese G., Dynamics of bone turnover in children with GH deficiency treated with GH until final height. European Journal of Endocrinology 2000 142 6 549 556 2-s2.0-0034084798 (Pubitemid 30399483)
42. Klefter O., Feldt-Rasmussen U., Is increase in bone mineral content caused by increase in skeletal muscle mass/strength in adult patients with GH-treated GH deficiency? A systematic literature analysis. European Journal of Endocrinology 2009 161 2 213 221 2-s2.0-68349146822 10.1530/EJE-09-0160
43. Proctor D. N., Melton L. J., Khosla S., Crowson C. S., O'Connor M. K., Riggs B. L., Relative influence of physical activity, muscle mass and strength on bone density. Osteoporosis International 2000 11 11 944 952 2-s2.0-0034517413 10.1007/s001980070033 (Pubitemid 32044075)
44. Frost H. M., The Utah paradigm of skeletal physiology: an overview of its insights for bone, cartilage and collagenous tissue organs. Journal of Bone and Mineral Metabolism 2000 18 6 305 316 2-s2.0-0033777443 10.1007/s007740070001
45. Giustina A., Mazziotti G., Canalis E., Growth hormone, insulin-like growth factors, and the skeleton. Endocrine Reviews 2008 29 5 535 559 2-s2.0-49549111375 10.1210/er.2007-0036
46. Kaur A., Phadke S. R., Analysis of short stature cases referred for genetic evaluation. The Indian Journal of Pediatrics 2012 79 12 1597 1600 10.1007/s12098-012-0732-x
47. Murray R. D., Skillicorn C. J., Howell S. J., Lissett C. A., Rahim A., Shalet S. M., Dose titration and patient selection increases the efficacy of GH replacement in severely GH deficient adults. Clinical Endocrinology 1999 50 6 749 757 2-s2.0-0033058987 10.1046/j.1365-2265.1999.00722.x (Pubitemid 29284509)
48. Pocock N. A., Noakes K. A., Griffiths M., Bhalerao N., Sambrook P. N., Eisman J. A., Freund J., A comparison of longitudinal measurements in the spine and proximal femur using lunar and hologic instruments. Journal of Bone and Mineral Research 1997 12 12 2113 2118 2-s2.0-0030734279 (Pubitemid 27524489)
49. Drake W. M., Rodríguez-Arnao J., Weaver J. U., James I. T., Coyte D., Spector T. D., Besser G. M., Monson J. P., The influence of gender on the short and long-term effects of growth hormone replacement on bone metabolism and bone mineral density in hypopituitary adults: a 5-year study. Clinical Endocrinology 2001 54 4 525 532 2-s2.0-0035723728 10.1046/j.1365-2265.2001. 01246.x (Pubitemid 34207705)
50. Olson L. E., Ohlsson C., Mohan S., The role of GH/IGF-I-mediated mechanisms in sex differences in cortical bone size in mice. Calcified Tissue International 2011 88 1 1 8 2-s2.0-78951485139 10.1007/s00223-010-9436-2
51. Carroll P. V., Drake W. M., Maher K. T., Metcalfe K., Shaw N. J., Dunger D. B., Cheetham T. D., Camacho-Hübner C., Savage M. O., Monson J. P., Comparison of continuation or cessation of growth hormone (GH) therapy on body composition and metabolic status in adolescents with severe GH deficiency at completion of linear growth. Journal of Clinical Endocrinology and Metabolism 2004 89 8 3890 3895 2-s2.0-4043091961 10.1210/jc.2003-031588 (Pubitemid 39071490)
52. Prabhakar V. K. B., Shalet S. M., Aetiology, diagnosis, and management of hypopituitarism in adult life. Postgraduate Medical Journal 2006 82 966 259 266 2-s2.0-33645923389 10.1136/pgmj.2005.039768
53. Woodhouse L. J., Mukherjee A., Shalet S. M., Ezzat S., The influence of growth hormone status on physical impairments, functional limitations, and health-related quality of life in adults. Endocrine Reviews 2006 27 3 287 317 2-s2.0-33646511089 10.1210/er.2004-0022
54. Hazem A., Elamin M. B., Bancos I., Malaga G., Prutsky G., Domecq J. P., Elraiyah T. A., Abu Elnour N. O., Prevost Y., Almandoz J. P., Zeballos-Palacios C., Velasquez E. R., Erwin P. J., Natt N., Montori V. M., Murad M. H., Body composition and quality of life in adults treated with GH therapy: a systematic review and meta-analysis. European Journal of Endocrinology 2012 166 1 13 20 10.1530/EJE-11-0558
55. Deijen J. B., Arwert L. I., Witlox J., Drent M. L., Differential effect sizes of growth hormone replacement on quality of life, well-being and health status in growth hormone deficient patients: a meta-analysis. Health and Quality of Life Outcomes 2005 3 63 2-s2.0-27744481492 10.1186/1477-7525-3-63 (Pubitemid 41582043)
56. Renehan A. G., Zwahlen M., Minder C., O'Dwyer S. T., Shalet S. M., Egger M., Insulin-like growth factor (IGF)-I, IGF binding protein-3, and cancer risk: systematic review and meta-regression analysis. The Lancet 2004 363 9418 1346 1353 2-s2.0-1942436958 10.1016/S0140-6736(04)16044-3 (Pubitemid 38529873)